1: (ROOT (S (S (NP (JJ New) (NNS Compounds)) (VP (VP (VBP Fight) (NP (NP (JJ Multiple)) (VBG VirusesAccording) (PP (IN to) (NP (NP (DT a) (NN report)) (PP (IN in) (NP (NP (NP (NNP ACS) (POS ')) (NNP Journal)) (PP (IN of) (NP (NNP Medicinal) (NNP Chemistry))))))))) (NP (NNS researchers)) (VP (VBP have) (VP (VBN discovered) (NP (NP (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG blocking) (NP (NP (NN replication)) (PP (PP (IN of) (NP (JJ similar) (NNS coronaviruses))) (CONJP (RB as) (RB well) (IN as)) (NP (JJ other) (ADJP (NN disease) (VBG causing)) (NNS viruses)))))))))))))))) (: ;) (CC but) (S (NP (DT the) (NNS compounds)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN tested) (PP (IN in) (NP (NNS humans))) (ADVP (RB yet)))))) (. .)))
2: (ROOT (S (S (NP (CD 201) (HYPH -) (NNP nCoV)) (VP (VBZ is) (NP (NP (DT a) (JJ close) (NN relative)) (PP (IN to) (NP (NP (NNP SARS)) (CONJP (RB as) (RB well) (IN as)) (NP (NNP MER) (HYPH -) (NNP CoV))))))) (, ,) (S (NP (NP (DT all)) (PP (IN of) (NP (DT these) (NNS viruses)))) (VP (VBP cause) (NP (ADJP (NN fl) (HYPH -) (JJ like)) (NNS symptoms)) (ADVP (CONJP (RB as) (RB well) (IN as)) (ADVP (RB frequently))) (VP (VBG leading) (PP (IN to) (NP (NN pneumonia)))))) (, ,) (CC and) (S (NP (EX there)) (VP (VBP have) (RB not) (VP (VBN been) (NP (DT any) (JJ effective) (NNS treatments)) (VP (VBN developed) (PP (IN as) (PP (IN of) (ADVP (RB yet)))))))) (. .)))
3: (ROOT (S (NP (NP (NNP Rolf) (NNP Hilgenfeld)) (, ,) (NP (NNP Hong) (NNP Liu)) (CC and) (NP (NNS colleagues))) (VP (VBP are) (VP (VBG working) (S (VP (TO to) (VP (VB develop) (NP (NP (DT a) (NML (JJ broad) (NN spectrum)) (NN antiviral)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB target) (NP (NP (NP (DT all) (NNS coronaviruses)) (CONJP (RB as) (RB well) (IN as)) (NP (NNS enteroviruses))) (, ,) (SBAR (WHNP (WHNP (DT all)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBP share) (NP (NP (JJ similar) (NN protein)) (VP (VBG cutting) (NP (NP (NP (NP (JJ main) (NN protease) (NNS enzymes)) (PP (IN in) (NP (NNS coronaviruses)))) (CC and) (NP (NP (DT the) (NN 3C) (NN protease)) (PP (IN in) (NP (NNS enteroviruses))))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADJP (JJ essential) (PP (IN for) (NP (DT the) (JJ viral) (NN replication)))))))))))))))))))))))) (. .)))
4: (ROOT (S (NP (NP (NN -ray) (NN crystal) (NNS structures)) (PP (IN of) (NP (DT the) (NNS proteases)))) (VP (VP (VBD were) (VP (VBN examined))) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN followed) (PP (IN by) (S (VP (VBG creating) (NP (NP (DT a) (NN series)) (PP (IN of) (NP (NP (NN -ketoamide) (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN predicted) (S (VP (TO to) (VP (VB fit) (PP (IN in) (NP (NP (DT the) (NN enzyme) (POS 's)) (JJ active) (NNS sites))) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (PRP$ their) (NN function)))))))))))))))))))))))) (. .)))
5: (ROOT (S (NP (NN Test) (NML (NML (NN tube)) (CC and) (NML (NN petri) (NN dish))) (NN testing)) (VP (VBD identified) (NP (NP (NP (CD one) (JJ versatile) (NN inhibitor)) (SBAR (WHNP (WDT that)) (S (VP (VBD blocked) (NP (JJ multiple) (NNS coronaviruses) (CC and) (NNS enteroviruses)))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT another) (NN molecule)) (SBAR (WHNP (WDT that)) (S (VP (VBD showed) (NP (JJ strong) (NN activity)) (PP (IN against) (NP (NNP MER) (HYPH -) (NNP CoV))) (PP (IN with) (NP (NP (JJ moderate) (NN activity)) (PP (IN against) (NP (JJ other) (NNS viruses))))))))))) (. .)))
6: (ROOT (S (PP (IN Due) (IN to) (S (NP (NP (DT the) (JJ main) (NNS proteases)) (PP (IN of) (NP (NP (NNP SAR) (HYPH -) (NNP CoV1)) (, ,) (NP (NNP MER) (HYPH -) (NNP CoV)) (, ,) (CC and) (NP (NNP SAR) (HYPH -) (CD Co-2))))) (VP (VBG being) (ADJP (RB very) (JJ similar))))) (NP (DT the) (NNS inhibitors)) (VP (MD will) (ADVP (RB likely)) (VP (VB have) (NP (NP (JJ good) (JJ antiviral) (NN activity)) (PP (IN against) (NP (DT the) (NNP Wuhan) (NN coronavirus)))) (, ,) (PP (VBG according) (PP (IN to) (NP (DT the) (NNS researchers)))))) (. .)))
7: (ROOT (S (NP (DT The) (JJ next) (NN phase)) (VP (MD will) (VP (VB be) (S (VP (TO to) (VP (VB test) (NP (DT these) (NNS inhibitors)) (PP (IN in) (NP (NP (NN animal) (NNS models)) (PP (IN of) (NP (NN disease))))) (PP (IN before) (S (ADVP (RB eventually)) (VP (VBG moving) (PP (IN onto) (NP (JJ human) (NN testing))))))))))) (. .)))
